Draconis Pharma S.L. is focused on providing scientific and technological services to pharmaceutical and biotechnology companies, aimed at supporting drug discovery at different stages of research, such as target validation, hit-finding, hit-to-lead and lead optimization towards the release of a robust and well-characterized preclinical candidate. Our scientific team comes entirely from the pharmaceutical R&D industry. They offer Draconis Pharma wide and proven experience in the different areas within drug discovery such as medicinal chemistry, analytical profiling, cell-based assays, in-vivo efficacy, ADME & PK and preliminary studies to determine toxicity and safety profiles.
Besides the service business, Draconis Pharma also participates in consortium and projects for the discovery and development of innovative technology or novel therapies for the treatment of inflammatory diseases and related disorders, such as Cancer.